CELC Stock Analysis: Buy, Sell, or Hold?
CELC - Celcuity Inc. Common Stock
$137.68
2.96 (2.20%)
▲
5d:
+5.05%
30d:
+9.92%
90d:
+31.74%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 18, 2026
0d
Smart Money Accumulation
CELC is down 10.7% this week, but smart money is accumulating calls. Top strike: $155 2026-06-18 with 3,288 OI. Call ratio: 60% View Scanner →
Strength: 6.4/10
Get Alerted When CELC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CELC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CELC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CELC is currently trading at $137.68, which is considered extended relative to its 30-day fair value range of $117.19 to $132.87.
Technical Outlook: Technically, CELC is in a strong uptrend. Immediate support is located at $121.65, while resistance sits at $151.02.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $159.90 (+16.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CELC is in a strong uptrend. Immediate support is located at $121.65, while resistance sits at $151.02.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $159.90 (+16.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$117.19 -
$132.87
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
48.4%
Protect Your Profits
Holding CELC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($159.90)
Trading Range Analysis
30-Day Trading Range
$117.19 -
$132.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$121.65
Resistance Level
$151.02
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-101.24
Wall Street Target
$159.90
(+16.1%)
Share & Embed Analysis
Last updated: May 18, 2026 7:09 AM ET
Data refreshes hourly during market hours. Next update: 8:09 AM
Data refreshes hourly during market hours. Next update: 8:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Richard E Buller
SELL
3000 shares
2026-03-31
David Dalvey
SELL
20000 shares
2026-01-27
Richard E Buller
SELL
3000 shares
2025-12-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 55 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$203 | 52 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 62 BUY |
Advanced CELC Option Strategies
Professional options setups generated by AI based on today's CELC price and gamma walls.
